SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001104659-21-049773
Filing Date
2021-04-13
Accepted
2021-04-13 16:24:57
Documents
12

Document Format Files

Seq Description Document Type Size
1 DEFM14A tm219536-9_defm14a.htm DEFM14A 6353843
2 GRAPHIC lg_reshapelife-4clr.jpg GRAPHIC 27536
3 GRAPHIC lg_obalon-4clr.jpg GRAPHIC 13297
4 GRAPHIC lg_mackenziepartninc-bw.jpg GRAPHIC 19514
5 GRAPHIC tm219536d1-ph_prduct4clr.jpg GRAPHIC 88167
6 GRAPHIC tm219536d1-ph_obalon4clr.jpg GRAPHIC 252499
7 GRAPHIC tm219536d1-lc_tblperce4clr.jpg GRAPHIC 95752
8 GRAPHIC tm219536d1-lc_meamtbl4clr.jpg GRAPHIC 122500
9 GRAPHIC tm219536d1-ph_nownext4clr.jpg GRAPHIC 175796
10 GRAPHIC lh_canaccord-4c.jpg GRAPHIC 35447
11 GRAPHIC tm219536d9-proxy_1obalbwlr.jpg GRAPHIC 424429
12 GRAPHIC tm219536d9-proxy_2obalbwlr.jpg GRAPHIC 357616
  Complete submission text file 0001104659-21-049773.txt   8574132
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-33818 | Film No.: 21823334
SIC: 3845 Electromedical & Electrotherapeutic Apparatus